Formononetin ameliorates oxaliplatin-induced peripheral neuropathy via the KEAP1-NRF2-GSTP1 axis

Management of oxaliplatin-induced peripheral neuropathy (OIPN) has proven challenging owing to the concern that any OIPN-preventing agents may also decrease the efficacy of the chemotherapeutic agent and fail to reverse established neuronal damage. Nevertheless, targeting redox signaling pathways co...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Yuan, Ye, Juan, Zhao, Bing, Sun, Jinbing, Gu, Na, Chen, Xi, Ren, Lingli, Chen, Jiao, Cai, Xueting, Zhang, Wenjuan, Yang, Yang, Cao, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451796/
https://www.ncbi.nlm.nih.gov/pubmed/32823168
http://dx.doi.org/10.1016/j.redox.2020.101677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451796/
https://www.ncbi.nlm.nih.gov/pubmed/32823168
http://dx.doi.org/10.1016/j.redox.2020.101677

Ejemplares similares